Table 4 Simple and multiple linear regression model (estimated value [95% confidence intervals]) for post index date of pneumonia (post-ID pneumonia) periods in chronic rhinosinusitis without nasal polyp compared to control group and subgroup analysis according to age and sex.

From: Association between chronic rhinosinusitis and pneumonia: a longitudinal follow-up study using a national health screening cohort

Characteristics

Mean ± SD in

CRS without nasal polyp group

Mean ± SD in

control group

Linear regression of CRS without nasal polyp for pneumonia

Simpleb

P value

Model 1bc

P value

Model 2bd

P value

Total participants (n = 15,445)

1-y post-ID pneumonia

0.11 ± 0.85

0.06 ± 0.60

0.051 (0.025 to 0.077)

 < 0.001a

0.025 (− 0.001 to 0.051)

0.056

0.035 (0.010 to 0.060)

0.007a

2-y post-ID pneumonia

0.09 ± 0.68

0.05 ± 0.59

0.042 (0.018 to 0.066)

0.001a

0.011 (− 0.013 to 0.035)

0.367

0.017 (− 0.006 to 0.041)

0.155

3-y post-ID pneumonia

0.11 ± 0.80

0.05 ± 0.54

0.059 (0.035 to 0.082)

 < 0.001a

0.033 (0.009 to 0.057)

0.007a

0.037 (0.014 to 0.061)

0.002a

Age < 60 years old (n = 9925)

1-y post-ID pneumonia

0.07 ± 0.65

0.03 ± 0.39

0.038 (0.015 to 0.060)

0.001a

0.021 (− 0.002 to 0.044)

0.068

0.025 (0.003 to 0.047)

0.027a

2-y post-ID pneumonia

0.06 ± 0.56

0.03 ± 0.38

0.036 (0.016 to 0.057)

0.001a

0.023 (0.002 to 0.044)

0.030a

0.026 (0.005 to 0.047)

0.014a

3-y post-ID pneumonia

0.09 ± 0.77

0.03 ± 0.39

0.054 (0.030 to 0.078)

 < 0.001a

0.035 (0.011 to 0.060)

0.005a

0.038 (0.013 to 0.062)

0.003a

Age ≥ 60 years old (n = 5520)

1-y post-ID pneumonia

0.19 ± 1.12

0.11 ± 0.86

0.075 (0.015 to 0.136)

0.014a

0.039 (− 0.022 to 0.099)

0.212

0.057 (− 0.001 to 0.115)

0.056

2-y post-ID pneumonia

0.15 ± 0.87

0.10 ± 0.84

0.052 (− 0.003 to 0.108)

0.066

− 0.003 (− 0.058 to 0.052)

0.917

0.008 (− 0.046 to 0.063)

0.771

3-y post-ID pneumonia

0.16 ± 0.85

0.09 ± 0.74

0.068 (0.018 to 0.118)

0.008a

0.035 (− 0.015 to 0.085)

0.174

0.042 (− 0.008 to 0.092)

0.097

Males (n = 8,520)

1-y post-ID pneumonia

0.10 ± 0.72

0.06 ± 0.60

0.035 (0.002 to 0.068)

0.037a

0.006 (− 0.027 to 0.039)

0.730

0.015 (− 0.017 to 0.047)

0.367

2-y post-ID pneumonia

0.09 ± 0.68

0.06 ± 0.60

0.036 (0.003 to 0.068)

0.032a

0.001 (− 0.032 to 0.033)

0.958

0.007 (− 0.025 to 0.039)

0.677

3-y post-ID pneumonia

0.12 ± 0.76

0.06 ± 0.59

0.066 (0.033 to 0.099)

 < 0.001a

0.040 (0.007 to 0.073)

0.019a

0.044 (0.011 to 0.077)

0.010a

Females (n = 6,925)

1-y post-ID pneumonia

0.13 ± 0.98

0.06 ± 0.60

0.071 (0.030 to 0.112)

0.001a

0.050 (0.008 to 0.091)

0.019a

0.060 (0.020 to 0.100)

0.004a

2-y post-ID pneumonia

0.10 ± 0.69

0.05 ± 0.57

0.050 (0.015 to 0.085)

0.005a

0.023 (− 0.013 to 0.058)

0.211

0.029 (− 0.006 to 0.064)

0.104

3-y post-ID pneumonia

0.10 ± 0.85

0.05 ± 0.48

0.050 (0.016 to 0.084)

0.004a

0.024 (− 0.010 to 0.058)

0.163

0.029 (− 0.004 to 0.063)

0.088

  1. CCI, Charlson comorbidity index; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; CRS, chronic rhinosinusitis; 1-y pre-ID pneumonia, pneumonia history from the date of CRS treatment (index date) to the date before 1-year periods; Post-ID pneumonia, the number of pneumonia diagnosis from the index date to the date after certain periods; SBP, systolic blood pressure; SD, standard deviation.
  2. aLinear regression model, Significance at P < 0.05.
  3. bModels were stratified by age, sex, income, and region of residence.
  4. cA model 1 was adjusted for obesity, smoking, alcohol consumption, total cholesterol, SBP, DBP, fasting blood glucose, CCI scores, asthma, and COPD.
  5. dA model 2 was adjusted for the model 1 plus 1-y pre-ID pneumonia.